Search

Displaying results 8961 - 8970 of 10000 in total
  1. Drug

    DCN-tCRK

    go.drugbank.com/drugs/DB18262
    Experimental

    DCN-tCRK is a recombinant, multi-functional fusion protein consisting of human decorin fused to the C-terminal vascular homing peptide tCRK.

  2. Drug

    HM15912

    go.drugbank.com/drugs/DB18266
    Investigational

    HM15912 is a human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment.

  3. Drug

    TAK-075 Free base

    go.drugbank.com/drugs/DB18268
    Experimental

    Synonyms: Pyrazolo(1,5-a)pyrimidine-3-carboxamide, n-(1-ethyl-1-(4-ethylphenyl)propyl)-4,5,6,7-tetrahydro-2,7,7-trimethyl-5-phenyl-, (5r)-Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    TLY-012

    go.drugbank.com/drugs/DB18336
    Experimental

    TLY-012 is a PEGylated recombinant human tumor necrosis factor-related apoptosis-inducing ligand (PEGylated TRAIL).[L48166]

  5. Drug

    ADVM-062

    go.drugbank.com/drugs/DB18341
    Experimental

    ADVM-062 is an adeno-associated virus vector carrying complementary deoxyribonucleic acid encoding the human long-wave-sensitive opsin 1 (AAV.7m8-L-opsin)

  6. Drug

    EB003

    go.drugbank.com/drugs/DB18362
    Experimental

    EB003 is a CRISPR-based sequence-specific antimicrobial (SSAM) targeted against shiga toxin-producing _E. coli_.

    Synonyms: Phage-derived, non-replicative delivery vector carrying a DNA payload encoding an RNA-guided nuclease that targets stx genes of Shiga toxin-producing Escherichia coli (STEC)
  7. Drug

    SMART101

    go.drugbank.com/drugs/DB18370
    Investigational

    SMART101 is an investigational cell therapy comprising human allogeneic CD34-CD7+ T cell progenitors that were cultured ex vivo.

  8. Drug

    PNT001

    go.drugbank.com/drugs/DB18375
    Investigational

    PNT001 is a humanized IgG4 S228P monoclonal antibody targeting the cis conformation of the phosphorylated Thr231-Pro232 motif in tau.

  9. Drug

    PYX-201

    go.drugbank.com/drugs/DB18382
    Investigational

    PYX-201 is an antibody-drug conjugate directed against the extra domain-B splice variant of fibronectin.

  10. Drug

    MDX-1097

    go.drugbank.com/drugs/DB18383
    Experimental

    MDX-1097 is a chimeric monoclonal antibody directed against the kappa myeloma antigen (KMA).